Which limits apply for Nitrosamines in medicinal products?
![](https://i.ytimg.com/vi/AUhSWYzmlRo/mqdefault.jpg)
26:42
How to use CPCA to define AI Limit of Nitrosamine?
![](https://i.ytimg.com/vi/y7mu29iHKok/mqdefault.jpg)
17:16
How to Define Limit For Newly Identified Nitrosamine Impurity?
![](https://i.ytimg.com/vi/OxC9kA62rSI/mqdefault.jpg)
17:30
5 WHYS | WHY WHY | SIMPLIFIED!
![](https://i.ytimg.com/vi/1oTzXV0paAc/mqdefault.jpg)
51:27
Applying Expert Knowledge for Nitrosamine Carcinogenicity Assessment
![](https://i.ytimg.com/vi/LO1k3RWwIUU/mqdefault.jpg)
26:07
How to define limit for unknown, known and total impurities
![](https://i.ytimg.com/vi/ily7ubaq-Lk/mqdefault.jpg)
1:22:14
Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs
![](https://i.ytimg.com/vi/cjhiP6HKV_4/mqdefault.jpg)
20:43
Frequently asked Interview Questions on OOS
![](https://i.ytimg.com/vi/pyfWVDPMKSI/mqdefault.jpg)
44:52